ChemicalBook--->CAS DataBase List--->1621375-32-3

1621375-32-3

1621375-32-3 Structure

1621375-32-3 Structure
IdentificationBack Directory
[Name]

4-(4-(4,5-dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
[CAS]

1621375-32-3
[Synonyms]

187295
4-(4-(2,4-dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
4-(4-(4,5-dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
Morpholine, 4-[4-(2,4-dibromo-1H-imidazol-1-yl)-2-thiazolyl]-
[Molecular Formula]

C10H10Br2N4OS
[MDL Number]

MFCD32206764
[MOL File]

1621375-32-3.mol
[Molecular Weight]

394.086
Chemical PropertiesBack Directory
[Boiling point ]

551.4±60.0 °C(Predicted)
[density ]

2.12±0.1 g/cm3(Predicted)
[storage temp. ]

Store at -20°C
[solubility ]

DMSO : 125 mg/mL (317.19 mM; Need ultrasonic)
[form ]

Solid
[pka]

2.01±0.50(Predicted)
[color ]

White to off-white
Hazard InformationBack Directory
[Biological Activity]

VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD), with IC50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with chromatin. VPC-14449 can be used for the research of prostate cancer[1][2]. VPC-14449 (0.01-100 μM; 24 h) inhibits AR-transcriptional activity and cell viability in LNCaP, C4-2, MR49F, and 22Rv1 cells[2].VPC-14449 (0.01-100 μM; 24 h) dose-dependently inhibits the transiently expressed full-length human AR in PC3 cells (IC50=0.34 μM) without affecting AR protein expression[1]. VPC-14449 (100 mg/kg; i.p. twice daily for 4 weeks) reduces tumor volume and abolishes PSA production with no decrease in body weight over a total duration 4 weeks in LNCaP xenograft model[1].
[References]

[1]. Dalal K, et, al. Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. J Biol Chem. 2014 Sep 19;289(38):26417-26429. [2]. Dalal K, et, al. Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions. Mol Cancer Ther. 2017 Oct;16(10):2281-2291.
1621375-32-3 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226 , 13588875226
Website: www.hzclap.com/en
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135 , +8613564774135
Website:
Company Name: ChemShuttle, Inc.  
Tel: 0510-83588313-802 18800520310;
Website: https://www.jiehuapharma.com/
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Wuxi KaideRui Pharmaceutical Technology Co., Ltd  
Tel: 19906241957
Website: www.chemicalbook.com/showsupplierproductslist20128/0.htm
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Website: https://www.chemicalbook.com/ShowSupplierProductsList927327/0.htm
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Website: https://www.targetmol.cn/
Company Name: Shenzhen Yaoyuan R&D Center Co., Ltd  
Tel: 13421666688 13421666688
Website: www.yaochemcial.com
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: Nanjing Shizhou Biology Technology Co.,Ltd  
Tel: 025-85560043 15850508050
Website: http://www.synzest.com
Tags:1621375-32-3 Related Product Information